Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 1—January 2020
Research

Phenotypic and Genotypic Correlates of Penicillin Susceptibility in Nontoxigenic Corynebacterium diphtheriae, British Columbia, Canada, 2015–2018

Jason Zou, Samuel D. Chorlton, Marc G. Romney, Michael Payne, Tanya Lawson, Anna Wong, Sylvie Champagne, Gordon Ritchie, and Christopher F. LoweComments to Author 
Author affiliations: St. Paul’s Hospital, Vancouver, British Columbia, Canada (J. Zou, M.G. Romney, M. Payne, T. Lawson, A. Wong, S. Champagne, G. Ritchie, C.F. Lowe); University of British Columbia, Vancouver (S.D. Chorlton, M.G. Romney, M. Payne, S. Champagne, G. Ritchie, C.F. Lowe)

Main Article

Figure

Distribution of MICs from antimicrobial susceptibility testing on Corynebacterium diphtheriae isolates collected at St. Paul’s Hospital, Vancouver, British Columbia, Canada during March 2015–September 2018. A) MICs from penicillin susceptibility testing. Green box indicates penicillin-susceptible breakpoints from the 2010 Clinical Laboratory Standards Institute (CLSI) M45 guidelines (30); red box indicates penicillin-susceptible breakpoints from the 2015 CLSI M45 guidelines (27). B) MICs for ery

Figure. Distribution of MICs from antimicrobial susceptibility testing on Corynebacterium diphtheriae isolates collected at St. Paul’s Hospital, Vancouver, British Columbia, Canada during March 2015–September 2018. A) MICs from penicillin susceptibility testing. Green box indicates penicillin-susceptible breakpoints from the 2010 Clinical Laboratory Standards Institute (CLSI) M45 guidelines (30); red box indicates penicillin-susceptible breakpoints from the 2015 CLSI M45 guidelines (27). B) MICs for erythromycin, clindamycin, and vancomycin susceptibility testing.

Main Article

References
  1. Galazka  A. The changing epidemiology of diphtheria in the vaccine era. J Infect Dis. 2000;181(Suppl 1):S2–9. DOIPubMedGoogle Scholar
  2. Vitek  CR, Wharton  M. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis. 1998;4:539–50. DOIPubMedGoogle Scholar
  3. Santos  LS, Sant’anna  LO, Ramos  JN, Ladeira  EM, Stavracakis-Peixoto  R, Borges  LL, et al. Diphtheria outbreak in Maranhão, Brazil: microbiological, clinical and epidemiological aspects. Epidemiol Infect. 2015;143:791–8. DOIPubMedGoogle Scholar
  4. Lodeiro-Colatosti  A, Reischl  U, Holzmann  T, Hernández-Pereira  CE, Rísquez  A, Paniz-Mondolfi  AE. Diphtheria outbreak in Amerindian communities, Wonken, Venezuela, 2016–2017. Emerg Infect Dis. 2018;24:1340–4. DOIPubMedGoogle Scholar
  5. Nanthavong  N, Black  AP, Nouanthong  P, Souvannaso  C, Vilivong  K, Muller  CP, et al. Diphtheria in Lao PDR: insufficient coverage or ineffective vaccine? PLoS One. 2015;10:e0121749. DOIPubMedGoogle Scholar
  6. du Plessis  M, Wolter  N, Allam  M, de Gouveia  L, Moosa  F, Ntshoe  G, et al. Molecular characterization of Corynebacterium diphtheriae outbreak isolates, South Africa, March–June 2015. Emerg Infect Dis. 2017;23:1308–15. DOIPubMedGoogle Scholar
  7. Mahomed  S, Archary  M, Mutevedzi  P, Mahabeer  Y, Govender  P, Ntshoe  G, et al. An isolated outbreak of diphtheria in South Africa, 2015. Epidemiol Infect. 2017;145:2100–8. DOIPubMedGoogle Scholar
  8. Meinel  DM, Kuehl  R, Zbinden  R, Boskova  V, Garzoni  C, Fadini  D, et al. Outbreak investigation for toxigenic Corynebacterium diphtheriae wound infections in refugees from Northeast Africa and Syria in Switzerland and Germany by whole genome sequencing. Clin Microbiol Infect. 2016;22:1003.e1–8. DOIPubMedGoogle Scholar
  9. Dangel  A, Berger  A, Konrad  R, Bischoff  H, Sing  A. Geographically diverse clusters of nontoxigenic Corynebacterium diphtheriae infection, Germany, 2016–2017. Emerg Infect Dis. 2018;24:1239–45. DOIPubMedGoogle Scholar
  10. Kantsone  I, Lucenko  I, Perevoscikovs  J. More than 20 years after re-emerging in the 1990s, diphtheria remains a public health problem in Latvia. Euro Surveill. 2016;21:30414. DOIPubMedGoogle Scholar
  11. Zasada  AA, Rastawicki  W, Rokosz  N, Jagielski  M. Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland. BMC Infect Dis. 2013;13:551. DOIPubMedGoogle Scholar
  12. Swart  EM, van Gageldonk  PG, de Melker  HE, van der Klis  FR, Berbers  GA, Mollema  L. Long-term protection against diphtheria in the Netherlands after 50 Years of vaccination: results from a seroepidemiological study. PLoS One. 2016;11:e0148605. DOIPubMedGoogle Scholar
  13. Lowe  CF, Bernard  KA, Romney  MG. Cutaneous diphtheria in the urban poor population of Vancouver, British Columbia, Canada: a 10-year review. J Clin Microbiol. 2011;49:2664–6. DOIPubMedGoogle Scholar
  14. Romney  MG, Roscoe  DL, Bernard  K, Lai  S, Efstratiou  A, Clarke  AM. Emergence of an invasive clone of nontoxigenic Corynebacterium diphtheriae in the urban poor population of Vancouver, Canada. J Clin Microbiol. 2006;44:1625–9. DOIPubMedGoogle Scholar
  15. Zasada  AA. Nontoxigenic highly pathogenic clone of Corynebacterium diphtheriae, Poland, 2004-2012. Emerg Infect Dis. 2013;19:1870–2. DOIPubMedGoogle Scholar
  16. Gubler  J, Huber-Schneider  C, Gruner  E, Altwegg  M. An outbreak of nontoxigenic Corynebacterium diphtheriae infection: single bacterial clone causing invasive infection among Swiss drug users. Clin Infect Dis. 1998;27:1295–8. DOIPubMedGoogle Scholar
  17. Farfour  E, Badell  E, Zasada  A, Hotzel  H, Tomaso  H, Guillot  S, et al. Characterization and comparison of invasive Corynebacterium diphtheriae isolates from France and Poland. J Clin Microbiol. 2012;50:173–5. DOIPubMedGoogle Scholar
  18. Dewinter  LM, Bernard  KA, Romney  MG. Human clinical isolates of Corynebacterium diphtheriae and Corynebacterium ulcerans collected in Canada from 1999 to 2003 but not fitting reporting criteria for cases of diphtheria. J Clin Microbiol. 2005;43:3447–9. DOIPubMedGoogle Scholar
  19. Viguetti  SZ, Pacheco  LG, Santos  LS, Soares  SC, Bolt  F, Baldwin  A, et al. Multilocus sequence types of invasive Corynebacterium diphtheriae isolated in the Rio de Janeiro urban area, Brazil. Epidemiol Infect. 2012;140:617–20. DOIPubMedGoogle Scholar
  20. Zasada  AA, Zaleska  M, Podlasin  RB, Seferynska  I. The first case of septicemia due to nontoxigenic Corynebacterium diphtheriae in Poland: case report. Ann Clin Microbiol Antimicrob. 2005;4:8. DOIPubMedGoogle Scholar
  21. Tiley  SM, Kociuba  KR, Heron  LG, Munro  R. Infective endocarditis due to nontoxigenic Corynebacterium diphtheriae: report of seven cases and review. Clin Infect Dis. 1993;16:271–5. DOIPubMedGoogle Scholar
  22. Griffith  J, Bozio  CH, Poel  AJ, Fitzpatrick  K, DeBolt  CA, Cassiday  P, et al. Imported toxin-producing cutaneous diphtheria–Minnesota, Washington, and New Mexico, 2015–2018. MMWR Morb Mortal Wkly Rep. 2019;68:281–4. DOIPubMedGoogle Scholar
  23. Wilson  AP. Treatment of infection caused by toxigenic and non-toxigenic strains of Corynebacterium diphtheriae. J Antimicrob Chemother. 1995;35:717–20. DOIPubMedGoogle Scholar
  24. Fricchione  MJ, Deyro  HJ, Jensen  CY, Hoffman  JF, Singh  K, Logan  LK. Non-toxigenic penicillin and cephalosporin-resistant Corynebacterium diphtheriae endocarditis in a child: a case report and review of the literature. J Pediatric Infect Dis Soc. 2014;3:251–4. DOIPubMedGoogle Scholar
  25. Mina  NV, Burdz  T, Wiebe  D, Rai  JS, Rahim  T, Shing  F, et al. Canada’s first case of a multidrug-resistant Corynebacterium diphtheriae strain, isolated from a skin abscess. J Clin Microbiol. 2011;49:4003–5. DOIPubMedGoogle Scholar
  26. FitzGerald  RP, Rosser  AJ, Perera  DN. Non-toxigenic penicillin-resistant cutaneous C. diphtheriae infection: a case report and review of the literature. J Infect Public Health. 2015;8:98–100. DOIPubMedGoogle Scholar
  27. Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria, 3rd edition (M45). Wayne (PA): The Institute; 2015.
  28. Clinical and Laboratory Standards Institute. Antimicrobial Susceptibility Testing Workshop Presentations. “Unusual suspects”—resistance concerns and susceptibility testing among less common, but noteworthy bacteria. Wayne (PA): the Institute; 2016 [cited 2019 Oct 2]. https://s3.amazonaws.com/AST_Meeting/June_2016+_Unusual_Suspects_Resistance_Concerns_and_Susceptibility_Testing_Among_Less_Common_but_Noteworthy_Bacteria.zip
  29. Bernard  K, Pacheco  AL. In vitro activity of 22 antimicrobial agents against Corynebacterium and Microbacterium species referred to the Canadian National Microbiology Laboratory. Clin Microbiol Newsl. 2015;37:187–98. DOIGoogle Scholar
  30. Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline. 2nd edition (M45–A2). Wayne (PA): the Institute; 2010.
  31. Larsen  MV, Cosentino  S, Rasmussen  S, Friis  C, Hasman  H, Marvig  RL, et al. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012;50:1355–61. DOIPubMedGoogle Scholar
  32. Jia  B, Raphenya  AR, Alcock  B, Waglechner  N, Guo  P, Tsang  KK, et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res. 2017;45(D1):D566–73. DOIPubMedGoogle Scholar
  33. Benamrouche  N, Hasnaoui  S, Badell  E, Guettou  B, Lazri  M, Guiso  N, et al. Microbiological and molecular characterization of Corynebacterium diphtheriae isolated in Algeria between 1992 and 2015. Clin Microbiol Infect. 2016;22:1005.e1–7. DOIPubMedGoogle Scholar
  34. Tauch  A, Bischoff  N, Brune  I, Kalinowski  J. Insights into the genetic organization of the Corynebacterium diphtheriae erythromycin resistance plasmid pNG2 deduced from its complete nucleotide sequence. Plasmid. 2003;49:63–74. DOIPubMedGoogle Scholar
  35. Coyle  MB, Minshew  BH, Bland  JA, Hsu  PC. Erythromycin and clindamycin resistance in Corynebacterium diphtheriae from skin lesions. Antimicrob Agents Chemother. 1979;16:525–7. DOIPubMedGoogle Scholar
  36. Schröder  J, Maus  I, Meyer  K, Wördemann  S, Blom  J, Jaenicke  S, et al. Complete genome sequence, lifestyle, and multi-drug resistance of the human pathogen Corynebacterium resistens DSM 45100 isolated from blood samples of a leukemia patient. BMC Genomics. 2012;13:141. DOIPubMedGoogle Scholar
  37. Fernández-Natal  I, Rodríguez-Lázaro  D, Marrodán-Ciordia  T, Sáez-Nieto  JA, Valdezate  S, Rodríguez-Pollán  H, et al. Characterization and antimicrobial susceptibility of one antibiotic-sensitive and one multidrug-resistant Corynebacterium kroppenstedtii strain isolated from patients with granulomatous mastitis. New Microbes New Infect. 2016;14:93–7. DOIPubMedGoogle Scholar
  38. Chorlton  SD, Ritchie  G, Lawson  T, Romney  MG, Lowe  CF. Whole-genome sequencing of Corynebacterium diphtheriae isolates recovered from an inner-city population demonstrates the predominance of a single molecular strain. J Clin Microbiol. 2019 Nov 20 [Epub ahead of print].
  39. Grosse-Kock  S, Kolodkina  V, Schwalbe  EC, Blom  J, Burkovski  A, Hoskisson  PA, et al. Genomic analysis of endemic clones of toxigenic and non-toxigenic Corynebacterium diphtheriae in Belarus during and after the major epidemic in 1990s. BMC Genomics. 2017;18:873. DOIPubMedGoogle Scholar
  40. Farfour  E, Badell  E, Dinu  S, Guillot  S, Guiso  N. Microbiological changes and diversity in autochthonous non-toxigenic Corynebacterium diphtheriae isolated in France. Clin Microbiol Infect. 2013;19:980–7. DOIPubMedGoogle Scholar
  41. Timms  VJ, Nguyen  T, Crighton  T, Yuen  M, Sintchenko  V. Genome-wide comparison of Corynebacterium diphtheriae isolates from Australia identifies differences in the Pan-genomes between respiratory and cutaneous strains. BMC Genomics. 2018;19:869. DOIPubMedGoogle Scholar

Main Article

Page created: December 18, 2019
Page updated: December 18, 2019
Page reviewed: December 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external